Epoetin 3000 IU is a recombinant human erythropoietin used for the management of various forms of anemia. It works by stimulating erythropoiesis (red blood cell production) in the bone marrow, leading to increased hemoglobin levels and improved oxygen-carrying capacity of blood. Epoetin 3000 IU is commonly prescribed in anemia associated with chronic kidney disease, cancer chemotherapy, HIV therapy, and in selected surgical patients to reduce the need for blood transfusions.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Indications

Epoetin 3000 IU is indicated for the treatment of:

• Anemia associated with chronic renal failure (CRF), including patients on dialysis and those not on dialysis

• Anemia in patients with non-myeloid malignancies receiving chemotherapy

• Anemic patients (hemoglobin >10 to <13 g/dL) scheduled for elective noncardiac, nonvascular surgery to reduce allogeneic blood transfusion requirements

• Anemia related to zidovudine therapy in HIV-infected patients

Therapeutic Class

• Drugs for Haemolytic, Hypoplastic & Renal Anemia

Pharmacology

Epoetin 3000 IU regulates erythropoiesis by stimulating the differentiation and proliferation of erythroid progenitor cells in the bone marrow. It promotes the release of reticulocytes into circulation and enhances hemoglobin synthesis. Recombinant epoetin (alfa or beta) mimics the action of endogenous erythropoietin and is effective in treating anemia related to chronic kidney disease, chemotherapy, and zidovudine therapy.

Dosage and Administration

Anemia in Chronic Renal Failure

• Adults: 50–100 IU/kg, three times weekly (IV or SC)

• Pediatrics: 50 IU/kg, three times weekly (IV or SC)

• Maintenance dose: Individualized; commonly 75 IU/kg TIW in dialysis patients

Anemia in Cancer Patients on Chemotherapy

• Adults: 150 IU/kg TIW SC or 40,000 IU SC weekly

• Pediatrics: 25–300 IU/kg, 3–7 times weekly

Surgery Patients

• 300 IU/kg/day SC for 10 days before surgery, on the day of surgery, and 4 days after

• Alternative: 600 IU/kg SC weekly prior to surgery plus a dose on surgery day

Zidovudine-treated HIV Patients

• Adults: 100 IU/kg TIW (IV or SC)

• Pediatrics: 50–400 IU/kg, 2–3 times weekly

Dose adjustments are made based on hematocrit and hemoglobin response under physician supervision.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Method of Administration

• Administer by IV injection over 1–2 minutes or subcutaneous injection

• Do not shake the vial

• Inspect visually for discoloration or particulate matter before use

• Not to be mixed with other drug solutions

Drug Interactions

• Hematinics may enhance therapeutic response

• Increased heparin requirement may be observed in dialysis patients

Contraindications

Epoetin 3000 IU is contraindicated in patients with:

• Uncontrolled hypertension

• Known hypersensitivity to epoetin or mammalian cell-derived products

Side Effects

• General: Headache, dizziness, fever, malaise, arthralgia

• Cardiovascular: Hypertension, palpitations

• Gastrointestinal: Nausea, vomiting, diarrhea, anorexia

• Others: Allergic reactions, occasional hyperkalemia

Pregnancy and Lactation

• Pregnancy Category C: Use only if clearly needed

• Caution is advised during breastfeeding as excretion in human milk is unknown

Precautions and Warnings

• Use cautiously in patients with controlled hypertension, ischemic vascular disease, seizure disorders, or known allergies

• Iron status should be evaluated before and during therapy

• Adequate iron supplementation is essential to ensure optimal response

Overdose

Doses up to 1500 IU/kg TIW have been used without direct toxicity. If hemoglobin exceeds target levels, therapy should be temporarily withheld. Phlebotomy may be required in cases of polycythemia.

Storage Conditions

• Store at 2°C to 8°C

• Protect from light

• Do not freeze or shake.